IMR Press / FBL / Special Issues / 1358015361194528769

Novel therapeutic approaches to cardiovascular diseases

Submission deadline: 31 December 2022
Special Issue Editors
Muntasir Billah
University of Sydney, Australia
Interests: Cardiovascular diseases, reperfusion injury, ischemia, autophagy, apoptosis, cell signaling, preconditioning
Cardiovascular disease
Molecular signaling
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Open Access Review
Microorganisms and cardiovascular diseases: importance of gut bacteria
Rashed Noor, Adiba Naz, Syeda Muntaka Maniha, Nafisa Tabassum, ... Muntasir Billah
Front. Biosci. (Landmark Ed) 2021, 26(5), 22–28;
(This article belongs to the Special Issue Novel therapeutic approaches to cardiovascular diseases)
Back to top